Homing peptides as targeted delivery vehicles
- 26 July 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 2 (7-8), 326-337
- https://doi.org/10.1039/c0ib00013b
Abstract
This review focuses on the discovery of homing peptides, their receptors and the applications for which they have been used.Keywords
This publication has 90 references indexed in Scilit:
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative PhosphorylationMolecular and Cellular Biology, 2010
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into TumorsCancer Cell, 2009
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProceedings of the National Academy of Sciences, 2009
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumoursBritish Journal of Cancer, 2009
- Targeting of albumin-embedded paclitaxel nanoparticles to tumorsNanomedicine: Nanotechnology, Biology and Medicine, 2008
- In Vivo Tumor Cell Targeting with “Click” NanoparticlesBioconjugate Chemistry, 2008
- Impaired angiogenesis in aminopeptidase N-null miceProceedings of the National Academy of Sciences, 2007
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000